These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11816373)

  • 1. [Scavenger effect of various cerebrovascular drugs].
    Horváth B; Márton Z; Halmosi R; Alexy T; Szapáry L; Vékási J; Bíró Z; Habon T; Késmárky G; Tóth K
    Orv Hetil; 2002 Jan; 143(1):13-7. PubMed ID: 11816373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine.
    Horvath B; Marton Z; Halmosi R; Alexy T; Szapary L; Vekasi J; Biro Z; Habon T; Kesmarky G; Toth K
    Clin Neuropharmacol; 2002; 25(1):37-42. PubMed ID: 11852295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro study of the hydroxyl scavenger effect of Cavinton.
    Oláh VA; Balla G; Balla J; Szabolcs A; Karmazsin L
    Acta Paediatr Hung; 1990; 30(2):309-16. PubMed ID: 2174249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of piracetam and vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture.
    Solanki P; Prasad D; Muthuraju S; Sharma AK; Singh SB; Ilavzhagan G
    Food Chem Toxicol; 2011 Apr; 49(4):917-22. PubMed ID: 21193009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D
    Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox.
    Franzoni F; Colognato R; Galetta F; Laurenza I; Barsotti M; Di Stefano R; Bocchetti R; Regoli F; Carpi A; Balbarini A; Migliore L; Santoro G
    Biomed Pharmacother; 2006 Sep; 60(8):453-7. PubMed ID: 16930933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative chemoreactome analysis of the synergism of vinpocetine, piracetam, and cinnarizine molecules].
    Gromova OA; Torshin IY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):69-76. PubMed ID: 35041315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroprotection strategies: effect of vinpocetine in vitro oxidative stress models].
    Pereira C; Agostinho P; Moreira PI; Duarte AI; Santos MS; Oliveira CR
    Acta Med Port; 2003; 16(6):401-6. PubMed ID: 15631851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrone derivatives of trolox as neuroprotective agents.
    Balogh GT; Vukics K; Könczöl A; Kis-Varga A; Gere A; Fischer J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3012-5. PubMed ID: 15896960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
    Horvath B; Vekasi J; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 40(2):165-6. PubMed ID: 19029641
    [No Abstract]   [Full Text] [Related]  

  • 12. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
    Kraus RL; Pasieczny R; Lariosa-Willingham K; Turner MS; Jiang A; Trauger JW
    J Neurochem; 2005 Aug; 94(3):819-27. PubMed ID: 16033424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of vinpocetine, pentoxifylline and nicergoline on red blood cell deformability.
    Hayakawa M
    Arzneimittelforschung; 1992 Feb; 42(2):108-10. PubMed ID: 1610415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scavenger effect of experimental and clinically used cardiovascular drugs.
    Marton Z; Halmosi R; Horvath B; Alexy T; Kesmarky G; Vekasi J; Battyany I; Hideg K; Toth K
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):745-53. PubMed ID: 11602821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vinpocetine in cerebrovascular diseases.
    Patyar S; Prakash A; Modi M; Medhi B
    Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the antioxidant activity of potential scavengers of nitric oxide].
    Kupková Z; Cerná H; Lojek A; Cíz M; Benes L
    Ceska Slov Farm; 2004 Nov; 53(6):310-3. PubMed ID: 15630998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant activity and free radical scavenging reactions of hydroxybenzyl alcohols. Biochemical and pulse radiolysis studies.
    Dhiman SB; Kamat JP; Naik DB
    Chem Biol Interact; 2009 Dec; 182(2-3):119-27. PubMed ID: 19665455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of L-tryptophan and pentoxiphylline on stress ulcer].
    Bülbüller N; Akkuş MA; Ilhan YS; Baysal F; Ozercan I; Aygen E; Kirkil C
    Ulus Travma Acil Cerrahi Derg; 2003 Apr; 9(2):90-5. PubMed ID: 12836101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.